Tissue Plasminogen Activator Use in Cardiac Arrest Secondary to Fulminant Pulmonary Embolism

BACKGROUND: Tissue plasminogen activator (tPA) is used emergently to dissolve thrombi in the treatment of fulminant pulmonary embolism. Currently, there is a relative contraindication to tPA in the setting of traumatic or prolonged cardiopulmonary resuscitation > 10 minutes because of the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousuf, Tariq, Brinton, Taylor, Ahmed, Khansa, Iskander, Joy, Woznicka, Daniel, Kramer, Jason, Kopiec, Adam, Chadaga, Amar R., Ortiz, Kathia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737028/
https://www.ncbi.nlm.nih.gov/pubmed/26858790
http://dx.doi.org/10.14740/jocmr2452w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737028/
https://www.ncbi.nlm.nih.gov/pubmed/26858790
http://dx.doi.org/10.14740/jocmr2452w

Ejemplares similares